Pilots

Technical Validation and Usability (TVU)

The CAREPATH will conduct Technical Validation and Usability (TVU) study to capture and fix usability issues before the clinical investigation starts, and to evaluate usability, users’ experience and safety of the CAREPATH ICT platform, by collecting feedback from stakeholders in the four pilot sites (SKB - Germany, UHCW - UK, SESCAM - Spain and CITST - Romania) across Europe.
TVU will involve 45 target end users (16 patients with MCI or mild dementia with their informal caregivers and 16 healthcare professionals from various disciplines), and will last 3 months (90 days).


45


End Users


16


Patients with MCI


16


Healthcare Professionals


TVU will consider adequate inclusion criteria for patients (like age, adequate visual and auditory acuity, presence of MCI and multimorbidity conditions), for informal caregivers (living situation, age, gender, skill to use electronic devices) and for professionale caregivers (type of health professional, if GP, medical doctor, nurse, etc., gender).

During TVU, each patient has to visit the participating physician at least 2 times, and will include:

Results of interviews and evaluation will be reported on appropriate modules.

Clinical Investigation (CI)

Clinical Investigation (CI) study will be a two-year campaign, to provide initial and indicative clinical validation of the implemented platform, involving 200 patients 100 users to pilot the CAREPATH platform and 100 patients as reference cases). It will be coordinated in the four European pilot sites (SKB, UHCW, SESCAM, CITST) with diverse health and social care systems, ICT landscape/digital maturity of healthcare provision and dementia national programs, which will allow for strengthening the evidence base on health outcomes and efficiency gains.


200


Patients


100


CAREPATH Platform


100


Reference Use Cases